Deal Announcements

Cappella Sings With $17 Million Venture Capital Funding

Wednesday, June 17, 2009 5:32:00 AM PDT | VentureDeal Staff

Ballybrit Galway, Ireland  --  Medical device company Cappella has secured $17.3 million for its series C round of institutional venture capital financing.

Cappella has developed what it calls "a novel solution for the treatment of coronary bifurcated disease."

Fountain Healthcare Partners and Mitsui & Co. Venture Partners led the round, which also included Enterprise Ireland, Polytechnos Venture Partners And ACT Venture Capital.  The company said the funding proceeds would be used to finance the launch of its new stent for bifurcated vascular disease.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1